Tuesday, 30 October 2018
George Washington University School of Medicine and Health Sciences
2100 Pennsylvania Avenue
Washington, DC 20007
+1 202 994 2987
According to the Pink Sheet, IND clinical holds by the US FDA have risen 36% since 2014. These holds cause major concerns for patients that an IND represents a glimmer of hope. Companies hoping to speed their drug candidate to market fear the impact that a clinical hold might have on their bottom line. We invite you to come participate in an interactive session that will cover the many reasons for clinical holds and a deep dive into appropriate steps to take to avoid them.
Join colleagues from the local regulatory community for an evening of networking and learn how to avoid the pitfall of a clinical hold. This event is sponsored by the RAPS DC/Baltimore chapter and is intended to promote knowledge sharing and engagement between regulatory and related professionals in our region. Attendees should arrive by 5:45 pm to participate in a drawing for special giveaways. Dinner will be provided and RAC holders may claim two RAC recertification credits.
Daniela Drago, RAC, PhD, director regulatory affairs programs at GW's School of Medicine and Health Sciences
Prior to 19 October:
On or after 19 October:
Contact RAPS Customer Service to register at the student registration rate (+1 301 770 2920 ext. 200).